Basics Taysha Gene Therapies, Inc. IPO Date: September 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $728.36M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 4.29% Avg Daily Range (30 D): $0.11 | 4.53% Avg Daily Range (90 D): $0.08 | 4.40% Institutional Daily Volume Avg Daily Volume: 1.29M Avg Daily Volume (30 D): 4.22M Avg Daily Volume (90 D): 2.67M Trade Size Avg Trade Size (Sh.): 217 Avg Trade Size (Sh.) (30 D): 209 Avg Trade Size (Sh.) (90 D): 216 Institutional Trades Total Inst.Trades: 289 Avg Inst. Trade: $2M Avg Inst. Trade (30 D): $.97M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .64M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.41M Avg Closing Trade (30 D): $1.08M Avg Closing Trade (90 D): $1.32M Avg Closing Volume: 957.32K     News Jun 3, 2025 @ 9:17 PM Taysha Gene Therapies Announces Details for Oral P... Source: N/A May 29, 2025 @ 2:40 AM Taysha Gene Therapies Announces Pricing of Public ... Source: N/A May 2, 2025 @ 12:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: N/A Mar 7, 2025 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: N/A Feb 7, 2025 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.34 $-.08 $-.07 Diluted EPS $-.34 $-.08 $-.07 Revenue $ 7.22M $ 2.3M $ 2.02M Gross Profit $ $ $ Net Income / Loss $ -86.77M $ -21.53M $ -18.79M Operating Income / Loss $ -88.55M $ -21.42M $ -19.93M Cost of Revenue $ $ $ Net Cash Flow $ -7.39M $ -22.44M $ -18.65M PE Ratio